Hyundai Bioscience Co. Ltd (048410) — Long-term Investment Intensity
Hyundai Bioscience Co. Ltd (048410) has a Long-term Investment Intensity of 3.1% as of December 2019. Long-term investments of ₩1.97 Billion represent 3.1% of total assets of ₩63.24 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check total reinvestment intensity of Hyundai Bioscience Co. Ltd to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Hyundai Bioscience Co. Ltd Long-term Investment Intensity (2014–2019)
This chart shows how Hyundai Bioscience Co. Ltd's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of December 2019, the intensity stands at 3.1%, reflecting long-term investments of ₩1.97 Billion against total assets of ₩63.24 Billion KRW. Explore debt repayment capacity of Hyundai Bioscience Co. Ltd to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Hyundai Bioscience Co. Ltd (2014–2019)
The table below presents the year-by-year Long-term Investment Intensity for Hyundai Bioscience Co. Ltd from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Hyundai Bioscience Co. Ltd (048410) market capitalisation.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 3.1% | ₩1.97 Billion | ₩63.24 Billion | ▲ +1.0 pp |
| 2018 | 2.1% | ₩1.16 Billion | ₩54.01 Billion | ▲ +1.0 pp |
| 2017 | 1.2% | ₩571.51 Million | ₩49.50 Billion | ▼ -0.3 pp |
| 2016 | 1.4% | ₩773.38 Million | ₩53.38 Billion | ▲ +0.1 pp |
| 2015 | 1.4% | ₩600.25 Million | ₩43.41 Billion | ▼ -0.4 pp |
| 2014 | 1.8% | ₩600.25 Million | ₩32.81 Billion | — |